The Noom Psychosocial GLP-1 Report

SUMMARY

GLP-1 medications create a powerful but temporary “habit window” by reducing cravings and freeing mental space for behavior change. While most people lose weight, long-term success depends on the habits built during treatment. Based on a ~5,000-person survey, the Noom Psychosocial GLP-1 Report finds over 90% adopt healthier behaviors, often triggering a cascade of positive changes. However, without support, many regain weight after stopping. Companion programs significantly improve habit formation, adherence, and maintenance—helping users sustain up to ~80% of weight loss at six months. Ultimately, lasting outcomes are driven not by the medication alone, but by behavior change, identity shifts, and ongoing support.